Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas. Read more.
« Concept phase of da Vinci Center project unveiled: Operating table for Third World Countries for $500 | Main | Presidents Announce VCU – William and Mary Health Policy and Law Initiative »